Height and kidney cancer risk: a meta-analysis of prospective studies

2014 ◽  
Vol 141 (10) ◽  
pp. 1799-1807 ◽  
Author(s):  
Sudong Liang ◽  
Gaofei Lv ◽  
Weikai Chen ◽  
Jianxin Jiang ◽  
Jingqun Wang
Author(s):  
Long-Gang Zhao ◽  
Zhuo-Ying Li ◽  
Guo-Shan Feng ◽  
Xiao-Wei Ji ◽  
Yu-Ting Tan ◽  
...  

ABSTRACT Here we provide a comprehensive meta-analysis to summarize and appraise the quality of the current evidence on the associations of tea drinking in relation to cancer risk. PubMed, Embase, and the Cochrane Database of Systematic Reviews were searched up to June 2020. We reanalyzed the individual prospective studies focused on associations between tea drinking and cancer risk in humans. We conducted a meta-analysis of prospective studies and provided the highest- versus lowest-category analyses, dose-response analyses, and test of nonlinearity of each association by modeling restricted cubic spline regression for each type of tea. We graded the evidence based on the summary effect size, its 95% confidence interval, 95% prediction interval, the extent of heterogeneity, evidence of small-study effects, and excess significance bias. We identified 113 individual studies investigating the associations between tea drinking and 26 cancer sites including 153,598 cancer cases. We assessed 12 associations for the intake of black tea with cancer risk and 26 associations each for the intake of green tea and total tea with cancer risk. Except for an association between lymphoid neoplasms with green tea, we did not find consistent associations for the highest versus lowest categories and dose-response analyses for any cancer. When grading current evidence for each association (number of studies ≥2), weak evidence was detected for lymphoid neoplasm (green tea), glioma (total tea, per 1 cup), bladder cancer (total tea, per 1 cup), and gastric and esophageal cancer (tea, per 1 cup). This review of prospective studies provides little evidence to support the hypothesis that tea drinking is associated with cancer risk. More well-designed studies are still needed to identify associations between tea intake and rare cancers.


SLEEP ◽  
2020 ◽  
Author(s):  
Angel T Y Wong ◽  
Alicia K Heath ◽  
Tammy Y N Tong ◽  
Gillian K Reeves ◽  
Sarah Floud ◽  
...  

Abstract Study Objectives To investigate the association between sleep duration and breast cancer incidence, we examined the association in a large UK prospective study and conducted a meta-analysis of prospective studies. Methods In the Million Women Study, usual sleep duration over a 24-h period was collected in 2001 for 713,150 participants without prior cancer, heart problems, stroke, or diabetes (mean age = 60 years). Follow-up for breast cancer was by record linkage to national cancer registry data for 14.3 years on average from the 3-year resurvey. Cox regression models yielded multivariable-adjusted breast cancer relative risks (RR) and 95% confidence intervals (CIs) for sleep duration categories. Published prospective studies of sleep duration and breast cancer risk were included in a meta-analysis, which estimated the inverse-variance weighted average of study-specific log RRs for short and for long versus average duration sleep. Results After excluding the first 5 years to minimize reverse causation bias in the Million Women Study, 24,476 women developed breast cancer. Compared with 7–8 h of sleep, the RRs for <6, 6, 9, and >9 h of sleep were 1.01 (95% CI, 0.95–1.07), 0.99 (0.96–1.03), 1.01 (0.96–1.06), and 1.03 (0.95–1.12), respectively. In a meta-analysis of 14 prospective studies plus the Million Women Study, including 65,410 breast cancer cases, neither short (RR < 7 h = 0.99 [0.98–1.01]) nor long (RR > 8 h = 1.01 [0.98–1.04]) versus average duration sleep was associated with breast cancer risk. Conclusions The totality of the prospective evidence does not support an association between sleep duration and breast cancer risk.


2012 ◽  
Vol 69 (12) ◽  
pp. 858-867 ◽  
Author(s):  
Sara Karami ◽  
Qing Lan ◽  
Nathaniel Rothman ◽  
Patricia A Stewart ◽  
Kyoung-Mu Lee ◽  
...  

Tumor Biology ◽  
2013 ◽  
Vol 34 (6) ◽  
pp. 3509-3517 ◽  
Author(s):  
Dan Wang ◽  
Omar Israel Vélez de-la-Paz ◽  
Jun-Xia Zhai ◽  
Dian-Wu Liu

Author(s):  
Francesca L. Crowe ◽  
Paul N. Appleby ◽  
Ruth C. Travis ◽  
Matt Barnett ◽  
Theodore M. Brasky ◽  
...  

2014 ◽  
Vol 136 (8) ◽  
pp. 1888-1898 ◽  
Author(s):  
Dagfinn Aune ◽  
Deborah A. Navarro Rosenblatt ◽  
Doris Sau Man Chan ◽  
Leila Abar ◽  
Snieguole Vingeliene ◽  
...  

2015 ◽  
Vol 26 (8) ◽  
pp. 1635-1648 ◽  
Author(s):  
D. Aune ◽  
D.A. Navarro Rosenblatt ◽  
D.S.M. Chan ◽  
S. Vingeliene ◽  
L. Abar ◽  
...  

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 1561-1561
Author(s):  
Cécile Pizot ◽  
Mathieu Boniol ◽  
Patrick Mullie ◽  
Alice Koechlin ◽  
Magali Boniol ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document